Newsfeeds - Spark Newswire

3 minute read

Surrozen Publishes Study In Translational Vision Science And Technology Demonstrating The Promise Of SZN-413 In Preclinical Models Of Diabetic Retinopathy

Today, 11:47 PM

Results highlight a potential novel treatment for diabetic and other retinopathies Unique Wnt-mediated mechanism increases vascular integrity, and transforms pathologic regrowth into physiological regrowth of retinal

SRZN

19 minute read

Options

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 11:47 PM

On Wednesday, 340 stocks hit new 52-week lows.

$APE

7 minute read

Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday

By Lisa Levin

Today, 11:47 PM

Gainers Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares jumped 187.3% to close at $48.03 on Monday after gaining around 18% on Friday.

AEMD

5 minute read

Carnival Surges Over 12%, Here’s 75 Biggest Movers From Friday

By Lisa Levin

Today, 11:47 PM

Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Schenker and USA Truck announced plans to combine and create premier North American transportation solutions provider.

AFRI

5 minute read

89 Biggest Movers From Friday

By Lisa Levin

Today, 11:47 PM

Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy.

ADN

3 minute read

33 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

Today, 11:47 PM

Gainers Revlon, Inc. (NYSE: REV) gained 81.5% to $3.54 following a report suggesting Reliance Industries is considering buying out the company, which recently filed for bankruptcy.

ACOR

2 minute read

Surrozen Initiates Dosing In Phase 1 Clinical Trial Of SZN-043 For Severe Alcoholic Hepatitis

By Benzinga Newsdesk

Today, 11:47 PM

Surrozen, Inc. (“Surrozen” or the “Company”) (NASDAQ:SRZN), a clinical-stage company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration,

SRZN